News for Humana Inc. (HUM.MX)

PR NewswireNEW YORK, June 7, 2025 NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Huma

Summary On June 6, 2025, Edelson Lechtzin LLP announced an investigation into Humana Inc (HUM) for potential violations of federal securities laws. The investig

NEWTOWN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks. Learn more about HUM stock here.

Summary: Humana reaffirms stable earnings guidance for 2025 aligning closely with analyst expectations. Analysts set a price target suggesting potential

Humana Inc. (HUM) has announced that its senior management team will engage with investors and analysts throughout June 2025. During these meetings, the compa

Barclays has adjusted its price target for Humana (HUM), reducing it from $322 to $273 while maintaining an Equal Weight rating for the stock. This change follo

PR NewswireNEW YORK, June 1, 2025 NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Hum

On May 30, 2025, Humana Inc. (HUM) announced a significant financial development by entering into a $5 billion unsecured revolving credit agreement. This agre

PR NewswireNEW YORK, May 26, 2025 NEW YORK, May 26, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Huma

Summary Humana Inc (HUM), through its philanthropic arm, the Humana Foundation, announced a $50,000 donation to support recovery efforts in Kentucky following d

The Humana Foundation, philanthropic arm of [url="]Humana Inc.[/url] (NYSE: HUM), announced today a $50,000 contribution to advance sustained recovery efforts

Shares of Humana Inc (HUM) fell 4.55% in mid-day trading on May 22. The stock reached an intraday low of $231.60, before recovering slightly to $234.59, dow

PR NewswirePLAINSBORO, N.J., May 22, 2025 With all doses of FDA-approved Wegovy® fully available nationwide, it is illegal under US compounding laws to ma

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (”œHumana” or the ”œCompany”) (:

Humana (HUM) shares dipped 4% after Medicare Advantage audits were intensified. Analyst 12-month price targets suggest a potential upside of 23.92% for

Shares of Humana Inc (HUM) surged 3.59% in mid-day trading on May 19. The stock reached an intraday high of $247.62, before settling at $246.51, up from its

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc.(”œHumana” or the ”œCompany”) (: H

Jim Cramer weighed in on the deepening crisis at one of America's largest health insurers, which has lately found itself under intense scrutiny by the public, regulators, and the media.